The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Bargain purchase gain, net of tax | 0 |
| Loss (gain) on disposal of fixed assets | 0 |
| Net loss | -94,981 |
| Depreciation and amortization | 5,824 |
| Loss on debt extinguishment | -4,654 |
| Impairment of operating lease right-of-use assets | 1,201 |
| Impairment of property and equipment | 2,185 |
| Non-cash interest expense | 7,325 |
| Amortization of debt discount and issuance costs on notes payable | 11,164 |
| Share-based compensation expense | 701 |
| Net accretion of premium on short-term investments | -532 |
| Accounts receivable | -879 |
| Inventory | 8,276 |
| Other current and non-current assets | -1,858 |
| Accounts payable | 496 |
| Accrued liabilities | 2,884 |
| Contract liabilities and other current liabilities | -399 |
| Operating lease liabilities | -3,036 |
| Other long-term liabilities | -457 |
| Unrealized (gain) loss on derivative liability | 5,709 |
| Unrealized gain on warrant liability | 4,422 |
| Inventory write-downs | 9,900 |
| Impairment of intangible assets | 10,100 |
| Net cash used in operating activities | -58,720 |
| Cash paid for ibeo business combination | 0 |
| Sales of investment securities | 30,134 |
| Purchases of investment securities | 51,859 |
| Advance to scantinel | 2,244 |
| Purchases of property and equipment | 679 |
| Net cash provided by (used in) investing activities | -24,648 |
| Principal proceeds from notes payable, net of debt discount and issuance costs | 0 |
| Principal payments under notes payable | 16,500 |
| Proceeds from stock option exercises | 8 |
| Net proceeds from issuance of common stock and warrants | 77,374 |
| Principal payments under finance leases | 13 |
| Net cash provided by financing activities | 60,869 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 316 |
| Change in cash, cash equivalents, and restricted cash | -22,183 |
| Cash, cash equivalents, and restricted cash at beginning of period | 56,247 |
| Cash, cash equivalents, and restricted cash at end of period | 34,064 |
MICROVISION, INC. (MVIS)
MICROVISION, INC. (MVIS)